Latest news

Latest Intelligence

• The evolution of the sales representative

  It's expected that HCPs will increasingly go to other channels for long-established and LoE products, where product awareness is already high.

• Interview: Trevor Smith, Takeda

  For Nycomed this meant loss of exclusivity (LOE) on its blockbuster gastroinestinal drug pantoprazole and the consequent need to reorganise its business.

Latest from PMHub

• RESONANT GROUP APPOINTS STEPHEN MARCHANT CHIEF DEVELOPMENT OFFICER

  We partner with pharmaceutical and biotech clients across the globe to educate and inspire clinicians by providing strategic support and tactical delivery of educational materials from phase II to LOE and

• RESONANT GROUP APPOINTS STEPHEN MARCHANT CHIEF DEVELOPMENT OFFICER

  We partner with pharmaceutical and biotech clients across the globe to educate and inspire clinicians by providing strategic support and tactical delivery of educational materials from phase II to LOE and

• Three strategies for managing loss of exclusivity successfully

  Consultant, Claire Taylor explains why you should be strategically planning your LOE strategy years in advance. ... Loss of exclusivity (LOE) is a natural milestone in a drug’s lifecycle.

• Three strategies for managing loss of exclusivity successfully

  Loss of exclusivity (LOE) is a natural milestone in a drug’s lifecycle. ... mind, just as we do for launch – LOE should be strategically planned for years in advance and carefully managed.

• Bigger than brand: Portfolio Positioning for Pharma

  For many years, Pharma have reduced the impact of loss of exclusivity (LOE) by launching alternative molecules to treat the same condition. ... However, with the impact of LOE fast approaching, it was vital that they widen their view to consider other